379 related articles for article (PubMed ID: 33965760)
1. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
2. CAR-NK Therapy: Translating a Novel Immunotherapy Treatment to Solid Organ Transplantation.
Loh K; Khan K; Kroemer A
Transplantation; 2020 Aug; 104(8):1523-1524. PubMed ID: 32732821
[No Abstract] [Full Text] [Related]
3. Advances in the treatment of graft-versus-host disease with immunomodulatory cells.
Yu Q; Wang H; Zhang L; Wei W
Int Immunopharmacol; 2021 Mar; 92():107349. PubMed ID: 33486323
[TBL] [Abstract][Full Text] [Related]
4. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells induce transplant immune tolerance.
Lu J; Li P; Du X; Liu Y; Zhang B; Qi F
Transpl Immunol; 2021 Aug; 67():101411. PubMed ID: 34020045
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
Front Immunol; 2022; 13():874157. PubMed ID: 35720402
[TBL] [Abstract][Full Text] [Related]
7. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
8. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
9. Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells.
Safinia N; Grageda N; Scottà C; Thirkell S; Fry LJ; Vaikunthanathan T; Lechler RI; Lombardi G
Front Immunol; 2018; 9():354. PubMed ID: 29535728
[TBL] [Abstract][Full Text] [Related]
10. The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.
Sayitoglu EC; Freeborn RA; Roncarolo MG
Front Immunol; 2021; 12():693105. PubMed ID: 34177953
[TBL] [Abstract][Full Text] [Related]
11. Can proliferation signal inhibitor-induced Tregs really reflect transplantation tolerance in clinical solid organ transplantation?
Li S; Kuang A; Huang R
Int Rev Immunol; 2009; 28(5):367-75. PubMed ID: 19811315
[TBL] [Abstract][Full Text] [Related]
12. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
[TBL] [Abstract][Full Text] [Related]
13. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
[TBL] [Abstract][Full Text] [Related]
14. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
15. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells.
Takasato F; Morita R; Schichita T; Sekiya T; Morikawa Y; Kuroda T; Niimi M; Yoshimura A
PLoS One; 2014; 9(2):e87722. PubMed ID: 24498362
[TBL] [Abstract][Full Text] [Related]
16. Induction of transplantation tolerance through regulatory cells: from mice to men.
Ferrer IR; Hester J; Bushell A; Wood KJ
Immunol Rev; 2014 Mar; 258(1):102-16. PubMed ID: 24517428
[TBL] [Abstract][Full Text] [Related]
17. Advances on CD8+ Treg Cells and Their Potential in Transplantation.
Bézie S; Anegon I; Guillonneau C
Transplantation; 2018 Sep; 102(9):1467-1478. PubMed ID: 29688996
[TBL] [Abstract][Full Text] [Related]
18. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
[TBL] [Abstract][Full Text] [Related]
20. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Janssens I; Cools N
Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
